HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-06-12FDA Approved: TIVICAY — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for TIVICAY (dolutegravir) from ViiV Healthcare Company, resulting in updated labeling per the suppl…
-
FDA approval · 2020-06-11FDA Approved: ZIDOVUDINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Zidovudine (AZT) by Aurobindo Pharma Limited. This approval supports a generic Zidovudine produc…
-
FDA approval · 2020-06-11FDA Approved: LAMIVUDINE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Lamivudine from Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2020-06-02Clinical Trial Update: Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO) [Phase 3]
Phase 3 clinical trial update for switching virologically suppressed HIV-1 adults to dolutegravir plus lamivudine (TANGO) with completed res…
-
CLINICAL_TRIALS trial_result · 2020-06-02Clinical Trial Update: CCTG 595: Text Messaging Intervention to Improve Adherence to PrEP in High-risk MSM [Phase 4]
Phase 4 clinical trial evaluating a text messaging intervention to improve adherence to PrEP among high-risk men who have sex with men; comp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-06-01Clinical Trial Update: Study to Assess the ART Impact on the Brain Outcomes. The ARBRE Study
A completed clinical trial (ARBRE Study) evaluating ART impact on brain outcomes in HIV-1 infection with cognitive impairment; results poste…
-
CLINICAL_TRIALS trial_result · 2020-05-22Clinical Trial Update: Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV Infection [Phase 4]
Phase 4 clinical trial update evaluating hepatitis B vaccination in HIV-positive individuals and those at high risk for HIV infection.
-
CLINICAL_TRIALS trial_result · 2020-05-19Clinical Trial Update: QDISS Stud: QD Isentress as Switch Strategy in Virologically Suppressed HIV-1 Infected-Patient [Phase 2]
Phase 2 trial evaluating QD Isentress as a switch strategy in virologically suppressed HIV-1 patients has completed.
-
FDA approval · 2020-05-15FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for a generic fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate (FTC/TDF). The…
-
FDA approval · 2020-05-14FDA Approved: EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Laurus Labs Limited)
FDA approved Laurus Labs' generic fixed-dose combination efavirenz, lamivudine, and tenofovir disoproxil fumarate for HIV-1 infection.
-
FDA approval · 2020-05-14FDA Approved: EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Laurus Labs Limited)
FDA approved Laurus Labs Limited's ANDA for a generic fixed-dose combination of efavirenz, lamivudine, and tenofovir disoproxil fumarate for…
-
CLINICAL_TRIALS trial_result · 2020-05-05Clinical Trial Update: Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation Study [Phase 1, Phase 2]
A dose-escalation Phase 1/2 trial evaluating short-term disulfiram administration to reverse latent HIV infection; results have been posted …
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: Trial of Vitamin D in HIV Progression, Birth Outcomes, and Child Health [Phase 3]
Phase 3 clinical trial evaluating the effects of Vitamin D on HIV progression, birth outcomes, and child health has completed.
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: Study to Optimize the Quality of Samples for Cell-mediated Immunity (CMI) in ART-naïve HIV-1-infected Subjects [NA]
Clinical trial update for a study assessing sample quality for cell-mediated immunity in ART-naïve HIV-1-infected subjects; study status com…
-
FDA approval · 2020-04-22FDA Approved: EVOTAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for EVOTAZ (atazanavir/cobicistat) submitted by E.R. Squibb & Sons, L.L.C.
-
CLINICAL_TRIALS trial_result · 2020-04-20Clinical Trial Update: Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens [Phase 4]
A Phase 4 trial comparing boosted atazanavir-based regimens to current effective HAART regimens in pediatric HIV shows equivalence, with res…
-
FDA approval · 2020-04-17FDA Approved: TROGARZO — Supplemental Application (Theratechnologies Inc.)
The FDA approved a supplemental Biologics License Application for TROGARZO (ibalizumab) from Theratechnologies Inc.
-
CLINICAL_TRIALS trial_result · 2020-04-14Clinical Trial Update: Shamba Maisha: Pilot Agricultural Intervention for Food Security and HIV Health Outcomes in Kenya [NA]
A completed pilot study assessing an agricultural intervention (Shamba Maisha) and its effects on HIV health outcomes and malnutrition in Ke…
-
FDA approval · 2020-04-08FDA Approved: ZIDOVUDINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a Zidovudine supplemental application submitted by Aurobindo Pharma Limited. This action updates Zidovudine's approval unde…
-
CLINICAL_TRIALS research · 2020-04-07Clinical Trial Update: Prospective Observational Epidemiologic Study of Maraviroc's Safety
Prospective observational epidemiologic study assessing safety of maraviroc in HIV patients; completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women [Phase 4]
Phase 4 trial assessing the effectiveness of integrating prenatal care to reduce HIV and sexually transmitted diseases among young pregnant …
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Buprenorphine and Integrated HIV Care [Phase 4]
Phase 4 trial update on buprenorphine with integrated HIV care for substance-related disorders and HIV/AIDS.
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Group Prenatal Care for Reducing the Risk of STDs in Pregnant Young Women [Phase 3]
Phase 3 trial evaluating group prenatal care to reduce risk of sexually transmitted diseases and HIV infections in pregnant young women has …
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Reducing Sex-Related HIV Risk Behaviors in Patients Receiving Treatment for Opioid Dependence [Phase 2]
Phase 2 clinical trial updating strategies to reduce sex-related HIV risk behaviors in patients being treated for opioid dependence; complet…
-
CLINICAL_TRIALS trial_result · 2020-04-02Clinical Trial Update: DRV/r + RPV QD: Efficacy and Toxicity Reduction [Phase 3]
Phase 3 trial update on DRV/r combined with RPV once daily showing efficacy and reduced toxicity in HIV treatment.